Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating.
NARecruitingINTERVENTIONAL
Enrollment
115
Participants
Timeline
Start Date
April 15, 2025
Primary Completion Date
December 1, 2025
Study Completion Date
December 1, 2025
Conditions
SIBO
Interventions
DRUG
Rifaximin (drug)
Rifaximin 0.4g bid for 2 weeks
Trial Locations (1)
250012
RECRUITING
Qilu Hospital of Shandong University, Jinan
All Listed Sponsors
lead
Xiuli Zuo
OTHER
NCT06772064 - Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating. | Biotech Hunter | Biotech Hunter